Nicolas Widmer (12 results)
Anarchy 52 June 1965 / Kingsley Widmer "The limits of Pacifism" / Colin Johnson "The fallacy of non-violent defence" / Nicolas and Ruth Walter "The Committee of 100 and anarchism" / Francis Ellingham "Automation & individualism" / Bosco Nedelcovic "Automation and work"
Kingsley Widmer "The limits of Pacifism" / Colin Johnson "The fallacy of non-violent defence" / Nicolas and Ruth Walter "The Committee of 100 and anarchism" / Francis Ellingham "Automation & individualism" / Bosco Nedelcovic "Automation and work"
Published by Freedom Press 1965
- Softcover
- Periodical
Seller: Shore Books, London, United KingdomShore Books
Contact seller5-star sellerCondition: Used - Very good
US$ 6.78
US$ 14.48 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Soft cover. Condition: Very Good. 36 pages. Kingsley Widmer "The limits of Pacifism" / Colin Johnson "The fallacy of non-violent defence" / Nicolas and Ruth Walter "The Committee of 100 and anarchism" / Francis Ellingham "Automation & individualism" / Bosco Nedelcovic "Automation and work" (SL#122).
Anarchy A Journal of Anarchist Ideas Number 52 June. 1965 /. . Kingsley Widmer "The limits of Pacifism" / Colin Johnson "The fallacy of non-violent defence" / Nicolas and Ruth Walter "The Committee of 100 and anarchism" / Francis Ellingham "Automation & Individualism" / Bosco Nedelcovic" .
Colin Ward (Editor) / Kingsley Widmer "The limits of Pacifism" / Colin Johnson "The fallacy of non-violent defence" / Nicolas and Ruth Walter "The Committee of 100 and anarchism" / Francis Ellingham "Automation & Individualism" / Bosco Nedelcovic"
Published by The Freedom Press 1965
- Softcover
- Periodical
Seller: Shore Books, London, United KingdomShore Books
Contact seller5-star sellerCondition: Used - Very good
US$ 13.56
US$ 14.48 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Soft cover. Condition: Very Good. 36 pages. Kingsley Widmer "The limits of Pacifism" / Colin Johnson "The fallacy of non-violent defence" / Nicolas and Ruth Walter "The Committee of 100 and anarchism" / Francis Ellingham "Automation & Individualism" / Bosco Nedelcovic" (SL#111).
The Limits of Pacifism - the Fallacy of Non-Violent Defence - the Committee of 100 and Anarchism - Automation and Individualism - Automation and the Idea of Work - Observations on Anarchy 47 - Observations on Anarchy 49 - Observations on Anarchy 48; Anarchy 52 (Vol. 5 No. 6) June 1965
Widmer, Kingsley; Colin Johnson; Nicolas & Ruth Walter; Francis Ellingham; Bosco Nedelcovic; James Gillespie; Joan Harvey; Jonn Roe
Published by Freedom Press, London 1965
- Softcover
- First Edition
Seller: Literary Cat Books, Machynlleth, Powys, WALES, United KingdomLiterary Cat Books
Contact seller4-star sellerAssociation member: IOBA
Condition: Used - Very good
US$ 11.39
US$ 19.75 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Softcover (Saddle-stapled). Condition: Very Good. No Dust Jacket. First Edition. Staples rusted. Slight wear and slight soiling to spine, cover and corners. ; With printed wrappers. ; 13.8x21.5x0.3 cm; (161-192) pages.
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG 2010
- Softcover
Seller: Books Puddle, New York, NY, U.S.A.Books Puddle
Contact seller4-star sellerCondition: New
US$ 138.34
US$ 3.99 shippingShips within U.S.A.Quantity: 4 available
Condition: New. pp. 248.
- Softcover
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
US$ 77.65
US$ 79.48 shippingShips from Germany to U.S.A.Quantity: 5 available
Taschenbuch. Condition: Neu. Imatinib plasma concentrations variability in oncologic patients | Is imatinib a candidate drug for a therapeutic drug monitoring program? | Nicolas Widmer | Taschenbuch | 248 S. | Englisch | 2010 | LAP LAMBERT Academic Publishing | EAN 9783838385112 | Verantwortliche Person für die EU: BoD - Books o…n Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.
More imagesMODERNITE DE L'ARCHITECTURE EN AFRIQUE réalisations des années 80
Hugo Houben - Hubert Guillaud - Thierry joffroy - Serge Maini - Alain Klein - Nicolas Widmer - Vincent Lietar - Pierre-Yves Perrot - Pascal Rollet - Djilali Najmi - Marc Nolhier - Jean-Loup Pivin -Pascal Martin Saint Léon - Catherine Robin - Olivier Scherrer
- Softcover
Seller: CANO, BREST, FranceCANO
Contact seller4-star sellerCondition: Used
US$ 23.39
US$ 73.80 shippingShips from France to U.S.A.Quantity: 1 available
Editions CRAterre 1989. 177 pages. Broché. Bon état. Avec des illustrations en noir et blanc.
Language: English
Published by LAP LAMBERT Academic Publishing Aug 2010 2010
- Softcover
- Print on Demand
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermanyBuchWeltWeit Ludwig Meier e.K.
Contact seller5-star sellerCondition: New
US$ 92.39
US$ 26.11 shippingShips from Germany to U.S.A.Quantity: 2 available
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The anticancer drug imatinib has transformed the treatment and prognosis of chronic myeloid leukemia and gastrointestinal stromal tumor. However, the treatment must be taken indefinitely and is not devoid of inconveniences and toxic…ity. Moreover, resistance or escape from disease control are occurring. Considering the large interindividual differences in the function of the enzymatic and transport systems involved in imatinib disposition, exposure to this drug can be expected to vary widely among patients. This book describes an observational clinical trial aiming at exploring the influence of these covariates on imatinib pharmacokinetics and assessing the interindividual variability of the pharmacokinetic parameters of the drug. A large interindividual variability was observed, together with some preliminary concentration-effect relationships. These elements are arguments to further investigate the potential benefit of a therapeutic drug monitoring program to optimize the use of imatinib in patients. Such results should be especially useful to clinical oncologists or scientists involved in clinical oncology research. 248 pp. Englisch.
- Softcover
- Print on Demand
Seller: moluna, Greven, Germanymoluna
Contact seller5-star sellerCondition: New
US$ 74.17
US$ 55.62 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Widmer Nicolasis a Swiss pharmacist who specialized both in Hospital Pharmacy and Clinical Pharmacology, and gained his PhD in Life Sciences in 2006. He is at present in charge of the Therapeutic Drug M…onitoring service at the Div.
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG 2010
- Softcover
- Print on Demand
Seller: Majestic Books, Hounslow, United KingdomMajestic Books
Contact seller4-star sellerCondition: New
US$ 141.41
US$ 8.56 shippingShips from United Kingdom to U.S.A.Quantity: 4 available
Condition: New. Print on Demand pp. 248 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG 2010
- Softcover
- Print on Demand
Seller: Biblios, frankfurt am main, HESSE, GermanyBiblios
Contact seller4-star sellerCondition: New
US$ 149.03
US$ 11.30 shippingShips from Germany to U.S.A.Quantity: 4 available
Condition: New. PRINT ON DEMAND pp. 248.
Language: English
Published by LAP LAMBERT Academic Publishing Aug 2010 2010
- Softcover
- Print on Demand
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000
Contact seller5-star sellerCondition: New
US$ 92.39
US$ 68.12 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The anticancer drug imatinib has transformed the treatment and prognosis of chronic myeloid leukemia and gastrointestinal stromal tumor. However, the treatment must be taken indefinitely and is not devoid of inconveniences and toxicity.… Moreover, resistance or escape from disease control are occurring. Considering the large interindividual differences in the function of the enzymatic and transport systems involved in imatinib disposition, exposure to this drug can be expected to vary widely among patients. This book describes an observational clinical trial aiming at exploring the influence of these covariates on imatinib pharmacokinetics and assessing the interindividual variability of the pharmacokinetic parameters of the drug. A large interindividual variability was observed, together with some preliminary concentration-effect relationships. These elements are arguments to further investigate the potential benefit of a therapeutic drug monitoring program to optimize the use of imatinib in patients. Such results should be especially useful to clinical oncologists or scientists involved in clinical oncology research.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 248 pp. Englisch.
- Softcover
- Print on Demand
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
US$ 92.39
US$ 70.33 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The anticancer drug imatinib has transformed the treatment and prognosis of chronic myeloid leukemia and gastrointestinal stromal tumor. However, the treatment must be taken indefinitely and is not devoid of inconveniences and toxicity.…Moreover, resistance or escape from disease control are occurring. Considering the large interindividual differences in the function of the enzymatic and transport systems involved in imatinib disposition, exposure to this drug can be expected to vary widely among patients. This book describes an observational clinical trial aiming at exploring the influence of these covariates on imatinib pharmacokinetics and assessing the interindividual variability of the pharmacokinetic parameters of the drug. A large interindividual variability was observed, together with some preliminary concentration-effect relationships. These elements are arguments to further investigate the potential benefit of a therapeutic drug monitoring program to optimize the use of imatinib in patients. Such results should be especially useful to clinical oncologists or scientists involved in clinical oncology research.
